Atrial Fibrillation (AFib) is the most common heart rhythm disorder, affecting more than 40 million people worldwide.
The condition poses a five-fold increased risk of stroke, yet is often difficult to detect.
Until now, studies have shown the potential of smart devices for large-scale AFib screening but have made no comparison with conventional screening.
However new research presented at the...
A call for independent policing of non-HIPAA health data. The Center for Democracy & Technology, a nonprofit organization focused on tech policy and architecture, and the eHealth Initiative & Foundation, a coalition of industry and academic stakeholders, yesterday released a framework proposal calling for self-regulation of consumer data use by health devices and products that don't...
Picking through the scraps. Following the bankruptcy of 'digital pill' maker Proteus Digital Health, business partner and stakeholder Otsuka Pharmaceutical has been approved to purchase the digital health company's assets by a federal bankruptcy court judge, STAT reports.
Otsuka's bid was challenged by Novartis, two former Proteus executives and other investors, who argued that the agreed upon $...
The accuracy of wearables employing photoplethysmography (PPG)-based heart rate sensors may vary significantly between specific devices and activity types, but these sensors’ performances do not appear to be significantly affected by the skin tone of the wearer, according to a new study published in NPJ Digital Medicine.
The investigation, conducted by Duke University researchers among 53...
Fitbit and Belgium-based FibriCheck announced today that device owners living in certain UK countries now have access to a smartwatch app that uses photoplethysmography (PPG) to detect heart rhythm irregularities such as atrial fibrillation.
Available in Belgium, the UK, the Netherlands and Ireland, the CE-marked tool is similar to FibriCheck’s smartphone app in that it uses light and sensors to...
